title: The vascular endothelial growth factor (VEGF)-E encoded by orf virus regulates keratinocyte proliferation and migration and promotes epidermal regeneration.
abstract: Vascular endothelial growth factor (VEGF)-A, a key regulator of cutaneous blood vessel formation, appears to have an additional role during wound healing, enhancing re-epithelialization. Orf virus, a zoonotic parapoxvirus, induces proliferative skin lesions that initiate in wounds and are characterized by extensive blood vessel formation, epidermal hyperplasia and rete ridge formation. The vascular changes beneath the lesion are largely due to viral-expressed VEGF-E. This study investigated using mouse skin models whether VEGF-E can induce epidermal changes such as that seen in the viral lesion. Injection of VEGF-E into normal skin increased the number of endothelial cells and blood vessels within the dermis and increased epidermal thickening and keratinocyte number. Injection of VEGF-E into wounded skin, which more closely mimics orf virus lesions, increased neo-epidermal thickness and area, promoted rete ridge formation, and enhanced wound re-epithelialization. Quantitative RT-PCR analysis showed that VEGF-E did not induce expression of epidermal-specific growth factors within the wound, but did increase matrix metalloproteinase (MMP)-2 and MMP-9 expression. In cell-based assays, VEGF-E induced keratinocyte migration and proliferation, responses that were inhibited by a neutralizing antibody against VEGF receptor (VEGFR)-2. These findings demonstrate that VEGF-E, both directly and indirectly, regulates keratinocyte function, thereby promoting epidermal regeneration.
authors.affiliation: Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand. lyn.wise@otago.ac.nz
authors.forename: Lyn M
authors.initials: LM
authors.lastname: Wise
authors.forename: Marie K
authors.initials: MK
authors.lastname: Inder
authors.forename: Nicola C
authors.initials: NC
authors.lastname: Real
authors.forename: Gabriella S
authors.initials: GS
authors.lastname: Stuart
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Fleming
authors.forename: Andrew A
authors.initials: AA
authors.lastname: Mercer
mesh_terms: D000818:Animals; D002465:Cell Movement; D049109:Cell Proliferation; D004817:Epidermis / Q000473:pathology*; D020869:Gene Expression Profiling; D015603:Keratinocytes / Q000187:drug effects*; D020778:Matrix Metalloproteinase 2 / Q000096:biosynthesis; D020780:Matrix Metalloproteinase 9 / Q000096:biosynthesis; D051379:Mice; D009923:Orf virus / Q000472:pathogenicity*; D060888:Real-Time Polymerase Chain Reaction; D012038:Regeneration; D014764:Viral Proteins / Q000378:metabolism*; D037521:Virulence Factors / Q000378:metabolism*
chemical_list: C084758:VEGF-like protein, Orf virus; D014764:Viral Proteins; D037521:Virulence Factors; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9